Submit Your Feeds

Business News • PR NewsWire • PIXUVRI® Launched In UK For Adult Patients With Multiply Relapsed Or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma

PIXUVRI® Launched In UK For Adult Patients With Multiply Relapsed Or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma
PIXUVRI® Launched In UK For Adult Patients With Multiply Relapsed Or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma

BIRMINGHAM, England, April 29, 2014 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced the launch of PIXUVRI® (pixantrone), the first new treatment for adult patients in the United Kingdom (UK) with multiply relapsed or refractory aggressive...

View More : http://www.prnewswire.com/news-releases/pixuvri-launched-in-uk-for-adult-patients-with-multiply-relapsed-or-refractory-a...
Releted News by prnewswire
Demand For Global Citizenship Programmes Primarily From Mideast, But Asia Is The Next Frontier
PIXUVRI® Launched In UK For Adult Patients With Multiply Relapsed Or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma
VCCircle Unveils a Free Company Research & Information Service Bizcircle
Home Sitemap Contact Us
© businessNewsNewsNews.com